Q460N5 (PAR14_HUMAN) Homo sapiens (Human)

Protein mono-ADP-ribosyltransferase PARP14 UniProtKBInterProSTRINGInteractive Modelling

1801 aa; Sequence (Fasta) ; (Isoform 1; Isoform 3; Isoform 4; Isoform 5)

Available Structures

46 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H5homo-2-mer7AG;1611-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor MCD72homo-2-merEGW;1613-1801
Assess
Crystal structure of human poly(ADP-ribose) polymerase 14, catalytic domain in complex with an inhi…homo-2-merXL2;1613-1801
Assess
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphatemonomerADP;791-1191
Assess
Human PARP14 (ARTD8, BAL2) - macro domains 1 and 2 in complex with adenosine-5-diphosphoribosemonomerAR6;791-1191
Assess
Human parp14 (artd8) - macro domain 2 in complex with adenosine-5-diphosphoribosemonomerAR6;999-1191
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor H10monomer7B8;1612-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK6monomerEE5;1612-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with an N-aryl piperazine inhibitormonomer94Z;1612-1801
Assess
PARP14 Macrodomain 2 with inhibitormonomer9HH;1002-1190
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with compound 3monomerTZ7;EDO;PEG;GOL;SO4;1613-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with inhibitor ITK1monomerEBB;1613-1801
Assess
crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[…monomer91V;1613-1801
Assess
Human poly(ADP-ribose) polymerase 14 (PARP14/ARTD8) - catalytic domain in complex with 6(5H)-phenan…monomerLDR;GOL;1613-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012759monomerXBA;EDO;1613-1801
Assess
Crystal structure of human poly(adp-ribose) polymerase 14, catalytic fragment in complex with an in…monomer3AB;1613-1801
Assess
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with A16(E)monomer0RZ;1613-1801
Assess
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a pyrimidine…monomerFDR;GOL;1614-1801
Assess
Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrah…monomer91J;1614-1801
Assess
Human Artd8 (Parp14, Bal2) - catalytic domain in complex with inhibitor A16(Z)monomer0RY;NO3;1615-1801
Assess
HUman PARP14 (ARTD8)-Macro domain 1 in complex with adenosine-5-diphosphoribosemonomerAPR;792-978
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN012042monomerXRM;CL;EDO;1615-1801
Assess
Human poly(ADP-ribose) polymerase 14 (Parp14/Artd8) - catalytic domain in complex with a quinazolin…monomerQDR;1615-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with compound 2monomerFDR;EDO;1616-1801
Assess
Human PARP14 (ARTD8), catalytic fragment in complex with RBN011980monomerYFG;1616-1801
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GTJ;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GV4;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;9KS;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;AWP;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GUY;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;GQY;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GUG;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;GW1;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GVV;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GUV;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;GVY;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;GV7;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GRY;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GRV;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GWA;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GT7;1208-1388
Assess
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3monomerBR;1208-1388
Assess
PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Str…monomerCL;DMS;GT4;1208-1388
Assess
PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with…monomerCL;DMS;GV1;1208-1388
Assess
HUMAN PARP14 (ARTD8, BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE- 5-DIPHOSPHORIBOSEmonomerAR6;1208-1388
Assess
The Crystal Structure of human PARP14 from Biortus.monomerGOL;CL;1208-1387
Assess

2 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomerAR6;0.863vfq.1.A791-1191
100.00
Assess
monomer0.735v7t.1.A1613-1801
100.00
Assess

11 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 1monomer0.907d2c.1.A1129-1305
100.00
Assess
Isoform 1monomerAR6;0.863vfq.1.A710-1110
100.00
Assess
Isoform 1monomer0.745v7t.1.A1532-1720
100.00
Assess
Isoform 3monomer0.907d2c.1.A927-1103
100.00
Assess
Isoform 3monomerAR6;0.863vfq.1.A508-908
100.00
Assess
Isoform 3monomer0.755v7t.1.A1330-1518
100.00
Assess
Isoform 4monomer0.907d2c.1.A1210-1386
100.00
Assess
Isoform 4monomerAR6;0.863vfq.1.A791-1191
100.00
Assess
Isoform 5monomer0.917d2c.1.A206-382
100.00
Assess
Isoform 5monomerAR6;0.863q71.1.A6-187
97.81
Assess
Isoform 5monomer91J;0.755v7w.1.A610-797
100.00
Assess

Alignments